secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0000950170-23-027758
Event type: m_and_a
Sentiment:  positive
Materiality: 0.65
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical completes $20M acquisition of RedPoint Medical3D's PSI assets
----------------------------------------------------------------------------

- Paid $20M cash at closing for RPM-3D assets used in pre-op planning and patient-specific guides for bunion surgery.
- Earnout up to $10M: $3.5M for transition services, $3.5M for tech milestones, up to $3M upon patent issuance.
- RPM-3D software integration with Lapiplasty system planned for 2023; commercial launch expected H2 2024.
- CEO says acquisition adds FDA-cleared PSI technologies, expanding customization for Lapiplasty and Adductoplasty.
- Entered non-compete/non-solicitation agreements with RPM-3D and consulting agreements with Dr. Adam Perler and James Spitler.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/0000950170-23-027758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023027758/tmci-20230612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer